{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05252390",
            "orgStudyIdInfo": {
                "id": "NUV-868-01"
            },
            "organization": {
                "fullName": "Nuvation Bio Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors",
            "officialTitle": "Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "nuv-as-monotherapy-and-in-combination-with-olaparib-or-enzalutamide-in-adult-patients-with-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-03-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-01-28",
            "studyFirstSubmitQcDate": "2022-02-11",
            "studyFirstPostDateStruct": {
                "date": "2022-02-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Nuvation Bio Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "NUV-868-01 is a first-in human, open- label, Phase 1/2 dose escalation and expansion study in patients with advanced solid tumors. The Phase 1 and 1b portions include patients with advanced solid tumors and are designed to determine the safety and the dose(s) of NUV-868 to be used as monotherapy and in combination with olaparib or enzalutamide for the Phase 2 portion. In Phase 2, NUV-868 in combination with olaparib or enzalutamide will be given to determine the safety and efficacy of these study treatments. One cohort of patients (with enzalutamide-na\u00efve metastatic castration-resistant prostate cancer) will be randomized to receive either NUV-868 monotherapy, enzalutamide monotherapy, or the combination of NUV-868 + enzalutamide. Patients will self-administer NUV-868 orally daily in 28-day cycles as monotherapy in Phases 1 and 2. In Phases 1b and 2, patients will self-administer NUV-868 orally daily in 28-day cycles in combination with olaparib or enzalutamide daily at standard prescribed doses (Phase 1b) or at the recommended Phase 2 combination dose (RP2cD) that is determined in Phase 1b. Patients will be treated until disease progression, toxicity, withdrawal of consent, or termination of the study."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Solid Tumor",
                "Ovarian Cancer",
                "Ovary Cancer",
                "Cancer of Ovary",
                "Cancer of the Ovary",
                "Ovary Neoplasm",
                "Pancreatic Cancer",
                "Pancreas Cancer",
                "Cancer of Pancreas",
                "Cancer of the Pancreas",
                "Pancreas Neoplasm",
                "Prostate Cancer",
                "Prostatic Cancer",
                "Cancer of Prostate",
                "Cancer of the Prostate",
                "Prostate Neoplasm",
                "Castrate Resistant Prostate Cancer",
                "Castration Resistant Prostatic Cancer",
                "Castration Resistant Prostatic Neoplasms",
                "Triple-negative Breast Cancer",
                "Triple Negative Breast Cancer",
                "Triple Negative Breast Neoplasms",
                "Breast Cancer",
                "Breast Carcinoma",
                "Cancer of Breast",
                "Cancer of the Breast",
                "Breast Tumor"
            ],
            "keywords": [
                "Phase 1",
                "Phase 2",
                "NUV-868",
                "olaparib",
                "enzalutamide",
                "Xtandi",
                "ovarian cancer",
                "pancreatic cancer",
                "metastatic castration-resistant prostate cancer",
                "triple-negative breast cancer",
                "Lynparza",
                "PARP inhibitor",
                "BET inhibitor",
                "BRCA mutation",
                "BRCA1",
                "BRCA2",
                "HRD",
                "HRR deficiency",
                "homologous recombination deficiency"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Sequential assignment will be applied in Phase 1 and Phase 1 b dose escalation cohorts. Parallel assignment will be applied in Phase 1b backfill cohorts and Phase 2.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 657,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1 Monotherapy",
                    "type": "EXPERIMENTAL",
                    "description": "NUV-868 will be administered at escalating dose levels until the maximum tolerated dose (MTD) is reached or a recommended Phase 2 dose (RP2D) is determined.",
                    "interventionNames": [
                        "Drug: NUV-868"
                    ]
                },
                {
                    "label": "Phase 1b Combination: NUV-868 + Olaparib",
                    "type": "EXPERIMENTAL",
                    "description": "NUV-868 will be administered at escalating dose levels in combination with olaparib until the recommended Phase 2 combination dose (RP2cD) is determined.\n\n300 mg olaparib will be administered orally twice daily throughout the 28-day cycles of NUV-868.",
                    "interventionNames": [
                        "Drug: NUV-868",
                        "Drug: Olaparib"
                    ]
                },
                {
                    "label": "Phase 1b Combination: NUV-868 + Enzalutamide",
                    "type": "EXPERIMENTAL",
                    "description": "NUV-868 will be administered daily at escalating dose levels in combination with enzalutamide until the RP2cD is determined.\n\n160 mg enzalutamide will be administered orally daily throughout the 28-day cycles of NUV-868.",
                    "interventionNames": [
                        "Drug: NUV-868",
                        "Drug: Enzalutamide"
                    ]
                },
                {
                    "label": "Phase 2 Combination: NUV-868 + Olaparib",
                    "type": "EXPERIMENTAL",
                    "description": "NUV-868 will be administered at the RP2cD.\n\nOlaparib will be administered at the RP2cD.",
                    "interventionNames": [
                        "Drug: NUV-868",
                        "Drug: Olaparib"
                    ]
                },
                {
                    "label": "Phase 2 Combination: NUV-868 + Enzalutamide",
                    "type": "EXPERIMENTAL",
                    "description": "NUV-868 will be administered at the RP2cD.\n\nEnzalutamide will be administered at the RP2cD.",
                    "interventionNames": [
                        "Drug: NUV-868",
                        "Drug: Enzalutamide"
                    ]
                },
                {
                    "label": "Phase 2: NUV-868 Monotherapy",
                    "type": "EXPERIMENTAL",
                    "description": "NUV-868 will be administered at the RP2D in one arm of a randomized Phase 2 combination (NUV-868 + enzalutamide) cohort.",
                    "interventionNames": [
                        "Drug: NUV-868"
                    ]
                },
                {
                    "label": "Phase 2: Enzalutamide Monotherapy",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "160 mg enzalutamide will be administered orally daily in one arm of a randomized Phase 2 combination (NUV-868 + enzalutamide) cohort.",
                    "interventionNames": [
                        "Drug: Enzalutamide"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NUV-868",
                    "description": "NUV-868 is an investigational drug for oral dosing.",
                    "armGroupLabels": [
                        "Phase 1 Monotherapy",
                        "Phase 1b Combination: NUV-868 + Enzalutamide",
                        "Phase 1b Combination: NUV-868 + Olaparib",
                        "Phase 2 Combination: NUV-868 + Enzalutamide",
                        "Phase 2 Combination: NUV-868 + Olaparib",
                        "Phase 2: NUV-868 Monotherapy"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Olaparib",
                    "description": "Olaparib",
                    "armGroupLabels": [
                        "Phase 1b Combination: NUV-868 + Olaparib",
                        "Phase 2 Combination: NUV-868 + Olaparib"
                    ],
                    "otherNames": [
                        "Lynparza"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Enzalutamide",
                    "description": "Enzalutamide",
                    "armGroupLabels": [
                        "Phase 1b Combination: NUV-868 + Enzalutamide",
                        "Phase 2 Combination: NUV-868 + Enzalutamide",
                        "Phase 2: Enzalutamide Monotherapy"
                    ],
                    "otherNames": [
                        "Xtandi"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1 Monotherapy Dose Escalation: Safety and tolerability of NUV-868 to determine the recommended Phase 2 dose (RP2D)",
                    "description": "Incidence of dose-limiting toxicities (DLTs)",
                    "timeFrame": "During the DLT period (28 days)"
                },
                {
                    "measure": "Phase 1b Dose Escalation, NUV-868 + Olaparib: Safety and tolerability of NUV-868 in combination with olaparib to determine the recommended Phase 2 combination dose (RP2cD)",
                    "description": "Incidence of DLTs",
                    "timeFrame": "During the DLT period (28 days)"
                },
                {
                    "measure": "Phase 1b Dose Escalation, NUV-868 + Olaparib: Pharmacokinetic (PK) profiles of NUV-868 and olaparib when administered in combination",
                    "description": "NUV-868 and olaparib combination PK",
                    "timeFrame": "Days 1, 8, and 29"
                },
                {
                    "measure": "Phase 1b Dose Escalation, NUV-868 + Enzalutamide: Safety and tolerability of NUV-868 in combination with enzalutamide to determine the RP2cD",
                    "description": "Incidence of DLTs",
                    "timeFrame": "During the DLT period (28 days)"
                },
                {
                    "measure": "Phase 1b Dose Escalation, NUV-868 + Enzalutamide: Pharmacokinetic (PK) profiles of NUV-868 and enzalutamide when administered in combination",
                    "description": "NUV-868 and enzalutamide combination PK",
                    "timeFrame": "Days 1, 8, and 57"
                },
                {
                    "measure": "Phase 2, NUV-868 + Olaparib: Change from Baseline in Tumor Imaging",
                    "description": "ORR per standard criteria",
                    "timeFrame": "Every 8 weeks during the first 24 weeks and then every 12 weeks, up to an average of 12 months (end of treatment)"
                },
                {
                    "measure": "Phase 2, NUV-868 + Olaparib: Change from Baseline in PSA measurements",
                    "description": "PSA50 response rate per standard criteria; only for patients with prostate cancer",
                    "timeFrame": "Every 4 weeks throughout study treatment, up to an average of 12 months (end of treatment)"
                },
                {
                    "measure": "Phase 2, NUV-868 + Enzalutamide in Enzalutamide-Na\u00efve Metastatic Castrate-Resistant Prostate Cancer (mCRPC): Time from First Dose to Disease Progression",
                    "description": "Radiographic progression-free survival (rPFS) per standard criteria",
                    "timeFrame": "Every 8 weeks during the first 24 weeks and then every 12 weeks, up to an average of 12 months (end of treatment)"
                },
                {
                    "measure": "Phase 2, NUV-868 + Enzalutamide in Enzalutamide-Resistant mCRPC: Response to Study Treatment",
                    "description": "Composite response rate (CRR: radiologic response, PSA50 response, and/or circulating tumor cell response) per standard criteria",
                    "timeFrame": "Every 4-12 weeks (time points vary depending on the type of response being evaluated) throughout study treatment, up to an average of 12 months (end of treatment)"
                },
                {
                    "measure": "Phase 1b Food Effect Substudy: Effect of Food on the Pharmacokinetics (PK) of NUV-868",
                    "description": "NUV-868 PK parameters in fed and fasted states",
                    "timeFrame": "Pre dose and 24 hours after the first and second doses of NUV-868, 7 days apart"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria For All Phases and Cohorts:\n\n1. Recovered from toxicity to prior anticancer therapy\n2. Adequate bone marrow and organ function\n3. No known active or symptomatic central nervous system (CNS) disease\n\nCohort-Specific Inclusion Criteria: In addition to the inclusion criteria listed above, the following criteria apply for enrollment into specific cohorts.\n\nPhase 1 (NUV-868 Monotherapy)\n\n1. Patients with advanced solid tumors that have progressed during or after treatment with approved therapies or for which there is no standard effective therapy available\n2. Life expectancy of \\> 3 months\n3. Eastern Cooperative Oncology Group Performance Status \u2264 2\n4. Measurable or non-measurable disease\n\nPhase 1b (NUV-868 in Combination With Enzalutamide or Olaparib)\n\n1. Life expectancy of \\> 3 months\n2. Eastern Cooperative Oncology Group Performance Status \u2264 2\n3. (Select cohorts only) Measurable disease\n4. Patient must be able to read and write sufficiently to document food intake and study drug dosing on the Dosing Diary or must have a caregiver who is willing and able to complete the Dosing Diary with the patient.\n5. One of the following tumor types:\n\n   1. Ovarian: Platinum-resistant OR platinum-refractory high grade serous ovarian, fallopian, or primary peritoneal cancer in the relapsed setting\n   2. Pancreatic: Pancreatic ductal adenocarcinoma (PDAC) with progression on or after treatment with at least one line of systemic chemotherapy in the advanced setting\n   3. Prostate: Histologically confirmed, metastatic adenocarcinoma of the prostate (adenocarcinoma/high grade carcinoma with neuroendocrine features is allowed) with progression on or after treatment with at least one NHT in the metastatic setting\n   4. Breast: Triple-negative breast cancer (TNBC) with progression on or after treatment with at least one line of systemic chemotherapy in the advanced setting\n   5. Other advanced tumors (only Phase 1b dose escalation, NUV-868 + olaparib): the study Medical Monitor must approve enrollment.\n   6. For all tumor types: Patients will be allowed in the study regardless of their BRCA/HRR status.\n\nPhase 2\n\n1. Life expectancy of \\> 6 months\n2. (Select cohorts only): At least one measurable lesion defined by standard criteria\n3. Eastern Cooperative Oncology Group Performance Status \u2264 1\n4. One of the following tumor types:\n\n   1. Ovarian: Platinum-resistant or platinum- refractory high grade serous ovarian, fallopian, or primary peritoneal cancer in the relapsed setting\n   2. Pancreatic: Progression on or after treatment with at least one line of systemic chemotherapy in the advanced setting\n   3. Prostate: Histologically confirmed, metastatic adenocarcinoma of the prostate (adenocarcinoma/high grade carcinoma with neuroendocrine features is allowed) with progression on or after treatment with at least one NHT in the metastatic setting\n   4. Breast: TNBC with progression on or after treatment with at least one line of systemic chemotherapy in the advanced setting\n\nKey Exclusion Criteria For All Phases and Cohorts:\n\n1. Have received chemotherapy, hormonal therapy (except for ongoing luteinizing hormone-releasing hormone \\[LHRH\\] analogs in male patients and premenopausal women), radiation, or biological anticancer therapy within 14 days prior to the first dose of NUV-868.\n2. Received treatment with an investigational agent for any indication within 14 days for non-myelosuppressive agent, or within 21 days or \\< 5 half-lives (whichever is longer) for myelosuppressive agent, prior to the first dose of study treatment.\n3. Requires medications that are known to be strong (or moderate for olaparib) inducers and/or strong (or moderate for olaparib) inhibitors of CYP3A4/5 enzymes.\n4. Female patients who are pregnant of breastfeeding.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nuvation Bio Inc.",
                    "role": "CONTACT",
                    "phone": "332-208-6102",
                    "email": "clinicaltrials@nuvationbio.com"
                }
            ],
            "locations": [
                {
                    "facility": "The University of Arizona Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85724",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tera Hennson",
                            "role": "CONTACT",
                            "phone": "520-626-1347",
                            "email": "tnhenson@arizona.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Ellison Institute of Technology",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90064",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mitchell Gross, MD",
                            "role": "CONTACT",
                            "phone": "310-272-7640",
                            "email": "mgross@eitm.org"
                        },
                        {
                            "name": "Nicole Rudin",
                            "role": "CONTACT",
                            "phone": "310-272-7640",
                            "email": "nrudin@eitm.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Hoag Memorial Hospital Presbyterian",
                    "status": "RECRUITING",
                    "city": "Newport Beach",
                    "state": "California",
                    "zip": "92663",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jericho Rabago",
                            "role": "CONTACT",
                            "phone": "949-764-6796",
                            "email": "Jericho.rabago@hoag.org"
                        },
                        {
                            "name": "Jason Ledesma",
                            "role": "CONTACT",
                            "phone": "949-764-4577",
                            "email": "Jason.ledesma@hoag.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.61891,
                        "lon": -117.92895
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers, LLP",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80012",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Hege, RN",
                            "role": "CONTACT",
                            "phone": "303-385-2067",
                            "email": "Jennifer.Hege@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Rocky Mountain, Cancer Centers, LLP",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Hege, RN",
                            "role": "CONTACT",
                            "phone": "303-385-2067",
                            "email": "Jennifer.Hege@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Rocky Mountain Cancer Centers, LLP",
                    "status": "RECRUITING",
                    "city": "Lone Tree",
                    "state": "Colorado",
                    "zip": "80124",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Hege, RN",
                            "role": "CONTACT",
                            "phone": "303-385-2067",
                            "email": "Jennifer.Hege@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.55171,
                        "lon": -104.8863
                    }
                },
                {
                    "facility": "H. Lee Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robin Neubauer",
                            "role": "CONTACT",
                            "phone": "813-745-1771",
                            "email": "Robin.Neubauer@moffitt.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21231",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John Torreverde",
                            "role": "CONTACT",
                            "phone": "410-955-1057",
                            "email": "jtorrev1@jhmi.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Xin Gao, MD",
                            "role": "CONTACT",
                            "phone": "617-724-4000",
                            "email": "xgao4@partners.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aaron Le",
                            "role": "CONTACT",
                            "phone": "313-576-8912",
                            "email": "lea@karmanos.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "St. Vincent-Frontier Cancer Center",
                    "status": "RECRUITING",
                    "city": "Billings",
                    "state": "Montana",
                    "zip": "59102",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Patrick Cobb, MD, FACO",
                            "role": "CONTACT",
                            "phone": "406-238-6290"
                        },
                        {
                            "name": "Tina Erhardt",
                            "role": "CONTACT",
                            "phone": "406-238-6962"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.78329,
                        "lon": -108.50069
                    }
                },
                {
                    "facility": "Morristown Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Morristown",
                    "state": "New Jersey",
                    "zip": "07960",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Salome Geene",
                            "role": "CONTACT",
                            "phone": "973-971-6373",
                            "email": "salome.geene@atlantichealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79677,
                        "lon": -74.48154
                    }
                },
                {
                    "facility": "Atlantic Health System / Overlook Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Summit",
                    "state": "New Jersey",
                    "zip": "07901",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Salome Greene",
                            "role": "CONTACT",
                            "phone": "973-971-6373",
                            "email": "salome.geene@atlantichealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71562,
                        "lon": -74.36468
                    }
                },
                {
                    "facility": "Laura & Isaac Perlmutter Cancer Center - NYU Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dayna Leis, RN",
                            "role": "CONTACT",
                            "phone": "347-266-2630",
                            "email": "Dayna.Leis@nyulangone.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Wassim Abida, MD",
                            "role": "CONTACT",
                            "phone": "646-422-4600",
                            "email": "abidam@mskcc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Carolina BioOncology Institute",
                    "status": "RECRUITING",
                    "city": "Huntersville",
                    "state": "North Carolina",
                    "zip": "28078",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ashley McClain",
                            "role": "CONTACT",
                            "phone": "980-441-1021",
                            "email": "AMcClain@carolinabiooncology.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.41069,
                        "lon": -80.84285
                    }
                },
                {
                    "facility": "Abramson Cancer Center of the U of Penn.",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Louie",
                            "role": "CONTACT",
                            "phone": "267-414-6179",
                            "email": "jennifer.louie2@pennmedicine.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Fox Chase Cancer Center",
                    "status": "COMPLETED",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "WITHDRAWN",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute - Tennessee Oncology",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "asksarah@sarahcannon.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Mary Crowley Cancer Research",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Douglas Orr, MD",
                            "role": "CONTACT",
                            "phone": "972-566-3000",
                            "email": "referral@marycrowley.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Texas Oncology - Baylor Charles A. Sammons Cancer Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christine Terraciano",
                            "role": "CONTACT",
                            "phone": "214-370-1942",
                            "email": "Christine.Terraciano@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Texas Oncology - Fort Worth Cancer Center",
                    "status": "RECRUITING",
                    "city": "Fort Worth",
                    "state": "Texas",
                    "zip": "76104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nori Sullivan, RN",
                            "role": "CONTACT",
                            "phone": "817-413-1760",
                            "email": "nori.sullivan@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.72541,
                        "lon": -97.32085
                    }
                },
                {
                    "facility": "Center for Oncology and Blood Disorders",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Luis Camacho, MD",
                            "role": "CONTACT",
                            "phone": "713-301-8964",
                            "email": "lhcamacho@cobd.us"
                        },
                        {
                            "name": "Johnathan Ojo",
                            "role": "CONTACT",
                            "phone": "832-540-1951",
                            "email": "jojo@clinvax.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "NEXT Virginia",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Valerie Strickland",
                            "role": "CONTACT",
                            "phone": "210-580-9500",
                            "email": "vstrickland@nextoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Virginia Oncology Associates",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Wendi Gobhardt",
                            "role": "CONTACT",
                            "phone": "757-213-5813",
                            "email": "wendi.gobhardt@usoncology.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "Macquarie University Hospital",
                    "status": "RECRUITING",
                    "city": "North Ryde",
                    "state": "New South Wales",
                    "zip": "2109",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "John Park",
                            "role": "CONTACT",
                            "phone": "61 2 9812 2956",
                            "email": "john.park@mqhealth.org.au"
                        },
                        {
                            "name": "Callum Rutherford",
                            "role": "CONTACT",
                            "phone": "61 2 9812 2959",
                            "email": "callum.rutherford@mq.edu.au"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.79677,
                        "lon": 151.12436
                    }
                },
                {
                    "facility": "Calvary Mater Hospital Newcastle",
                    "status": "RECRUITING",
                    "city": "Waratah",
                    "state": "New South Wales",
                    "zip": "2298",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Howard Chan",
                            "role": "CONTACT",
                            "phone": "61 2 4014 3563",
                            "email": "howard.chan@calvarymater.org.au"
                        },
                        {
                            "name": "Saba Kugashiya",
                            "role": "CONTACT",
                            "phone": "61 2 4014 3291",
                            "email": "saba.kugashiya@calvarymater.org.au"
                        }
                    ],
                    "geoPoint": {
                        "lat": -32.90667,
                        "lon": 151.72647
                    }
                },
                {
                    "facility": "Cabrini Hospital Malvern",
                    "status": "RECRUITING",
                    "city": "Malvern",
                    "state": "Victoria",
                    "zip": "3144",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Shehara Mendis",
                            "role": "CONTACT",
                            "phone": "1300 300 977",
                            "email": "shehara.mendis@mh.org.au"
                        },
                        {
                            "name": "Dina Cherfi",
                            "role": "CONTACT",
                            "phone": "61 3 9508 3596",
                            "email": "DCherfi@cabrini.com.au"
                        }
                    ],
                    "geoPoint": {
                        "lat": -32.02849,
                        "lon": 151.32225
                    }
                },
                {
                    "facility": "Peter Maccallum Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3000",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Arun Azad",
                            "role": "CONTACT",
                            "phone": "61 3 8559 5000",
                            "email": "arun.azad@petermac.org"
                        },
                        {
                            "name": "Richelle Linklater",
                            "role": "CONTACT",
                            "phone": "61 3 8559 5000",
                            "email": "Richelle.Linklate@petermac.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "Linear Clinical Research",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Michael Millward",
                            "role": "CONTACT",
                            "phone": "+61(0)419395975",
                            "email": "michael.millward@uwa.edu.au"
                        },
                        {
                            "name": "Kyle Summers",
                            "role": "CONTACT",
                            "phone": "+61(08) 6382 5115",
                            "email": "ksummers@linear.org.au"
                        }
                    ],
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                },
                {
                    "id": "D000010190",
                    "term": "Pancreatic Neoplasms"
                },
                {
                    "id": "D000010051",
                    "term": "Ovarian Neoplasms"
                },
                {
                    "id": "D000064726",
                    "term": "Triple Negative Breast Neoplasms"
                },
                {
                    "id": "D000064129",
                    "term": "Prostatic Neoplasms, Castration-Resistant"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000010049",
                    "term": "Ovarian Diseases"
                },
                {
                    "id": "D000000291",
                    "term": "Adnexal Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000006058",
                    "term": "Gonadal Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12974",
                    "name": "Ovarian Neoplasms",
                    "asFound": "Cancer of the Ovary",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "asFound": "Cancer of Pancreas",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30373",
                    "name": "Triple Negative Breast Neoplasms",
                    "asFound": "Triple Negative Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1704",
                    "name": "Carcinoma, Ovarian Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M30215",
                    "name": "Prostatic Neoplasms, Castration-Resistant",
                    "asFound": "Castration-Resistant Prostatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12972",
                    "name": "Ovarian Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3643",
                    "name": "Adnexal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M9163",
                    "name": "Gonadal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4352",
                    "name": "Ovarian Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4354",
                    "name": "Ovarian Epithelial Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000531550",
                    "term": "Olaparib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000067856",
                    "term": "Poly(ADP-ribose) Polymerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M233003",
                    "name": "Olaparib",
                    "asFound": "Improvement",
                    "relevance": "HIGH"
                },
                {
                    "id": "M205",
                    "name": "Poly(ADP-ribose) Polymerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}